Northern Trust’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7M Buy
219,613
+18,832
+9% +$137K ﹤0.01% 3061
2025
Q4
$1.23M Sell
200,781
-17,053
-8% -$184K ﹤0.01% 3263
2025
Q3
$4.01M Sell
217,834
-3,199
-1% -$51.4K ﹤0.01% 2633
2025
Q2
$2.88M Sell
221,033
-29,018
-12% -$343K ﹤0.01% 2791
2025
Q1
$2.65M Sell
250,051
-6,281
-2% -$99.7K ﹤0.01% 2771
2024
Q4
$4.35M Buy
256,332
+13,582
+6% +$256K ﹤0.01% 2586
2024
Q3
$5.63M Buy
242,750
+12,435
+5% +$266K ﹤0.01% 2407
2024
Q2
$5.61M Sell
230,315
-6,627
-3% -$201K ﹤0.01% 2332
2024
Q1
$8M Sell
236,942
-10,057
-4% -$356K ﹤0.01% 2186
2023
Q4
$7.79M Buy
246,999
+18,235
+8% +$433K ﹤0.01% 2232
2023
Q3
$5.84M Buy
228,764
+910
+0.4% +$28K ﹤0.01% 2351
2023
Q2
$6.53M Buy
227,854
+15,682
+7% +$427K ﹤0.01% 2352
2023
Q1
$5.09M Sell
212,172
-1,086
-0.5% -$19.5K ﹤0.01% 2466
2022
Q4
$3.62M Buy
213,258
+5,863
+3% +$102K ﹤0.01% 2676
2022
Q3
$3.07M Sell
207,395
-1,501
-0.7% -$25.2K ﹤0.01% 2773
2022
Q2
$3.29M Buy
208,896
+15,187
+8% +$298K ﹤0.01% 2780
2022
Q1
$5.22M Sell
193,709
-8,443
-4% -$215K ﹤0.01% 2565
2021
Q4
$7.48M Sell
202,152
-3,118
-2% -$127K ﹤0.01% 2440
2021
Q3
$9.81M Sell
205,270
-30,769
-13% -$1.38M ﹤0.01% 2281
2021
Q2
$7.99M Sell
236,039
-8,259
-3% -$280K ﹤0.01% 2529
2021
Q1
$10.1M Sell
244,298
-42,074
-15% -$2.51M ﹤0.01% 2287
2020
Q4
$12.4M Buy
286,372
+43,457
+18% +$2.94M ﹤0.01% 2107
2020
Q3
$10.4M Buy
242,915
+27,992
+13% +$1.39M ﹤0.01% 2089
2020
Q2
$10M Buy
214,923
+177,363
+472% +$6.11M ﹤0.01% 2092
2020
Q1
$510K Buy
37,560
+930
+3% +$11.9K ﹤0.01% 3443
2019
Q4
$398K Buy
36,630
+13,899
+61% +$145K ﹤0.01% 3607
2019
Q3
$233K Buy
+22,731
New +$246K ﹤0.01% 3721

Other funds holding ARCT